Regulon

Regulon: R-1387

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
102.2734417Pr-108Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5141 ENSG00000065989 PDE4A P27815
51172 ENSG00000103174 NAGPA Q9UK23
23646 ENSG00000105223 PLD3 A0A024R0Q4
25789 ENSG00000105696 TMEM59L Q9UK28
7277 ENSG00000127824 TUBA4A P68366
146691 ENSG00000175662 TOM1L2 Q6ZVM7
79751 ENSG00000177542 SLC25A22 Q9H936
27132 ENSG00000178773 CPNE7 Q9UBL6
5575 ENSG00000188191 PRKAR1B P31321
55753 ENSG00000197444 OGDHL Q9ULD0

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ERIBULIN MESYLATETUBB1Small moleculeINHIBITORTubulin inhibitor40
SAGOPILONETUBB1Small moleculeSTABILISERTubulin stabiliser22
AGS-16C3FTUBB1UnknownDISRUPTING AGENTTubulin disrupting agent20
TELISOTUZUMAB VEDOTINMETAntibodyBINDING AGENTHepatocyte growth factor receptor binding agent30
DOCETAXELTUBB1Small moleculeINHIBITORTubulin inhibitor40
FOSBRETABULIN DISODIUMTUBB1Small moleculeINHIBITORTubulin inhibitor20
CHF-6001PDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
VINCRISTINETUBB1Small moleculeINHIBITORTubulin inhibitor43
VINFLUNINETUBB1Small moleculeINHIBITORTubulin inhibitor40
LEXIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor21
VINCRISTINE SULFATETUBB1Small moleculeINHIBITORTubulin inhibitor43
TRASTUZUMAB EMTANSINEERBB2AntibodyINHIBITORTubulin inhibitor40
ENFORTUMAB VEDOTINTUBB1AntibodyBINDING AGENTNectin-4 binding agent40
VINORELBINE TARTRATETUBB1Small moleculeINHIBITORTubulin inhibitor40
LIFASTUZUMAB VEDOTINTUBB1AntibodyBINDING AGENTSodium-dependent phosphate transport protein 2B binding agent20
KOS-1584TUBB1Small moleculeSTABILISERTubulin stabiliser20
APREMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor40
PRALUZATAMAB RAVTANSINEALCAMAntibodyINHIBITORTubulin inhibitor20
DYPHYLLINEPDE3ASmall moleculeINHIBITORPhosphodiesterase 3A inhibitor40
OGLEMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
LADIRATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor20
FLAVOXATE HYDROCHLORIDEPDE4ASmall moleculeINHIBITORPhosphodiesterase 8 inhibitor40
PACLITAXELTUBB1Small moleculeINHIBITORTubulin inhibitor41
CROLIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor10
MK-0873PDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
TOFIMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
PACLITAXEL POLIGLUMEXTUBB1Small moleculeSTABILISERTubulin stabiliser30
PATUPILONETUBB1Small moleculeSTABILISERTubulin stabiliser31
PENTOXIFYLLINEPDE4ASmall moleculeANTAGONISTAdenosine A2 receptor antagonist40
ASG-5METUBB1AntibodyINHIBITORTubulin inhibitor10
ANG1005LRP1ProteinBINDING AGENTProlow-density lipoprotein receptor-related protein 1 binding agent32
DROTAVERINEPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor30
PINATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor10
DIPYRIDAMOLESLC29A1Small moleculeINHIBITOR3',5'-cyclic phosphodiesterase inhibitor40
VERUBULINTUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent22
VINBLASTINE SULFATETUBB1Small moleculeINHIBITORTubulin inhibitor40
VINORELBINETUBB1Small moleculeINHIBITORTubulin inhibitor42
DAVUNETIDETUBB1ProteinSTABILISERTubulin stabiliser20
BELANTAMAB MAFODOTINTUBB1AntibodyBINDING AGENTTumor necrosis factor receptor superfamily member 17 binding agent40
FOSBRETABULINTUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent30
IBUDILASTPDE3ASmall moleculeINHIBITORPhosphodiesterase 3A inhibitor31
MIRVETUXIMAB SORAVTANSINEFOLR1AntibodyINHIBITORTubulin inhibitor30
GSK-256066PDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
ROFLUMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor40
IXABEPILONETUBB1Small moleculeINHIBITORTubulin inhibitor41
POLATUZUMAB VEDOTINTUBB1AntibodyBINDING AGENTB-cell antigen receptor complex-associated protein beta chain binding agent40
T-900607TUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent20
DIFAMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor30
APRUTUMAB IXADOTINTUBB1AntibodyBINDING AGENTFibroblast growth factor receptor 2 binding agent10
PLINABULINTUBB1Small moleculeINHIBITORTubulin inhibitor30
TISOTUMAB VEDOTINF3AntibodyBINDING AGENTCoagulation factor III binding agent40
DOLASTATIN-10TUBB1Small moleculeINHIBITORTubulin inhibitor20
FOSBRETABULIN TROMETHAMINETUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent20
CILOMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor30
SAR-408701TUBB1UnknownBINDING AGENTCarcinoembryonic antigen-related cell adhesion molecule 5 binding agent30
CABAZITAXELTUBB1Small moleculeINHIBITORTubulin inhibitor42
FLAVOXATEPDE8BSmall moleculeINHIBITORPhosphodiesterase 8 inhibitor40
PACLITAXEL DOCOSAHEXAENOIC ACIDTUBB1Small moleculeSTABILISERTubulin stabiliser30
ERIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor40
BMS-275183TUBB1Small moleculeSTABILISERTubulin stabiliser20
INDUSATUMAB VEDOTINTUBB1AntibodyBINDING AGENTHeat-stable enterotoxin receptor binding agent20
CRISABOROLEPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor40
GLEMBATUMUMAB VEDOTINTUBB1AntibodyBINDING AGENTTransmembrane glycoprotein NMB binding agent20
COLCHICINETUBB1Small moleculeINHIBITORTubulin inhibitor40
VANDORTUZUMAB VEDOTINSTEAP1AntibodyINHIBITORTubulin inhibitor10
VINBLASTINETUBB1Small moleculeINHIBITORTubulin inhibitor40
BRENTUXIMAB VEDOTINTNFRSF8AntibodyINHIBITORTubulin inhibitor40
TETOMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor30
AMLEXANOXPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor40
EPOTHILONE DTUBB1Small moleculeSTABILISERTubulin stabiliser20
SOFITUZUMAB VEDOTINTUBB1AntibodyBINDING AGENTMucin-16 binding agent10
INDIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor10
OXTRIPHYLLINEPDE4ASmall moleculeINHIBITORPhosphodiesterase 3 inhibitor40
AZINTUXIZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor10
HT-0712PDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
LOTAMILASTPDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
LAROTAXELTUBB1Small moleculeSTABILISERTubulin stabiliser30
RG-7841TUBB1UnknownINHIBITORTubulin inhibitor10
CC-11050PDE4ASmall moleculeINHIBITORPhosphodiesterase 4 inhibitor20
LORVOTUZUMAB MERTANSINENCAM1AntibodyINHIBITORTubulin inhibitor20
THEOPHYLLINEADORA1Small moleculeINHIBITORPhosphodiesterase 3 inhibitor40
AMINOPHYLLINEPDE3ASmall moleculeINHIBITORPhosphodiesterase 3 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1387

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-02046TCHHdown-regulatesSREBF2activatesR-138751Drugs (82)
CMF-12463PTDSS1down-regulatesSREBF2activatesR-138751Drugs (82)
CMF-14319STK31down-regulatesSREBF2activatesR-138751Drugs (82)
CMF-17669DPY19L2P1down-regulatesSREBF2activatesR-138751Drugs (82)
CMF-24228WBSCR17down-regulatesSREBF2activatesR-138751Drugs (82)
CMF-27228HTR3Adown-regulatesSREBF2activatesR-138751Drugs (82)
CMF-30393CLCN7down-regulatesSREBF2activatesR-138751Drugs (82)